当前位置: X-MOL 学术Gastroenterology › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
EUS-Guided Transluminal Interventions
Gastroenterology ( IF 29.4 ) Pub Date : 2018-02-16 , DOI: 10.1053/j.gastro.2017.12.046
Uzma D. Siddiqui , Michael J. Levy

The role of endoscopic ultrasound (EUS) has transitioned from a diagnostic to a therapeutic one over the past 40 years. With the advent of curvilinear array echoendoscopes in the 1990s with an accessory channel, multiple tools and devices have been developed and used for a variety of transluminal interventions. EUS provides a viable option and is becoming the procedure of choice for many interventions, including bile and pancreatic duct drainage, guiding angiotherapy, pancreatic fluid collection management, gallbladder drainage, and creating a gastrojejunostomy. Although reports demonstrate the technical success of these interventions, there is tremendous study heterogeneity and a relative lack of controlled randomized trials, which may limit our understanding of their role and utility. Furthermore, adverse events are relatively common and occasionally severe. Despite the limitations, available data strongly indicate the efficacy of EUS interventions when performed by well-trained endosonographers in carefully selected patients and managed in a multidisciplinary setting.



中文翻译:

EUS引导的腔内介入治疗

在过去的40年中,内窥镜超声(EUS)的作用已从诊断性转变为治疗性。随着1990年代带有附件通道的曲线阵列超声内窥镜的出现,已经开发出了多种工具和设备并将其用于各种腔内介入治疗。EUS提供了一个可行的选择,并且正在成为许多干预措施的首选程序,包括胆汁和胰管引流,指导血管疗法,胰液收集管理,胆囊引流和开胃空肠造口术。尽管报告显示了这些干预措施的技术成功,但仍存在巨大的研究异质性和相对缺乏对照随机试验的情况,这可能会限制我们对它们的作用和效用的理解。此外,不良事件相对常见,有时甚至很严重。尽管存在局限性,但可用数据强烈表明,由训练有素的内窥镜检查人员对精心挑选的患者进行EUS干预,并在多学科环境中进行治疗。

更新日期:2018-02-16
down
wechat
bug